Tepecik Education and Research Hospital Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2013
NCT01917396
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

İzmi̇r Tepeci̇k Eği̇ti̇m Ve Arştırma Hastanesi̇ | Tepecik Research and Training Hospital | Tepecik Training and Research Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

rabeprazole (pariet) (1 trial)

Drugs in Phase 3 Trials (3)

azithromycin (zithromax) (1 trial)

favipiravir (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

Drugs in Other Trials (3)

oxygen (1 trial)

propolis (1 trial)

sodium phosphate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gastroesophageal Reflux (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7